comparemela.com
Home
Live Updates
Zhaoke Ophthalmology Announces 2022 Interim Results : comparemela.com
Zhaoke Ophthalmology Announces 2022 Interim Results
- Zhaoke Ophthalmology Limited , a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet... | August 24, 2022
Related Keywords
China ,
Guangzhou ,
Guangdong ,
Japan ,
Zhongshan ,
Anhui ,
Shanghai ,
Hong Kong ,
Xiaomei ,
Zhejiang ,
Suzhou ,
Jiangsu ,
Nansha ,
Peking ,
Beijing ,
Macau ,
Chinese ,
Chen Youxin ,
Zhaoke Boshi Wechat ,
Iris Pei ,
Diana Footitt ,
Bowen Chui ,
Li Xiaoyi Benjamin ,
Wang Ningli ,
Zhaoke Boshi ,
Yang Xiao ,
Vyluma Inc ,
Co Ltd ,
China Resources Pharmaceutical Commercial Group ,
Zhaoke Ophthalmology Limited ,
Union Medical College Hospital ,
Artemis Associates ,
John Hopkins University ,
Sinopharm Group Distribution Co Ltd ,
Hong Kong Stock Exchange ,
Zhongshan Ophthalmic Center ,
National Medical Products Administration ,
Sun Yat Sen University ,
Shanghai Pharmaceuticals Co Ltd ,
Our Company ,
Hospital Of Fudan University ,
Ophthalmology Limited ,
Executive Director ,
Heat Compress Eyepatch ,
Compress Eyepatch ,
Csa Ophthalmic Gel ,
New Drug Application ,
Drug Evaluation ,
Medical Products Administration ,
Resources Pharmaceutical Commercial Group Limited ,
Reporting Period ,
Ophthalmic Gel ,
Professor Wang Ningli ,
Tongren Hospital ,
Fudan University ,
Ophthalmic Center ,
Zhaoke Guangzhou ,
Bimatoprost Timolol ,
Main Board ,
Kong Stock Exchange ,
Japan Corporate News ,
Zhaoke Ophthalmology Limited Stock Exchange ,
News ,
Information ,
Press Release ,
Zhaoke ,
Ophthalmology ,
Imited ,
Reading ,
Ophthalmic ,
Harmaceutical ,
Company ,
Edicated ,
O ,
The ,
Research ,
End ,
Manufacturing ,
Ommercialization ,
F ,
Therapies ,
Hat ,
Address ,
Ignificant 6622 Kyg989m51017 ,
comparemela.com © 2020. All Rights Reserved.